King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3913-3918. doi: 10.26355/eurrev_201806_15276.
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is an evolving global health crisis. Despite recent efforts, there are numerous notable gaps in the understanding of MERS-CoV seasonal diversity. We aimed at investigating the global seasonal occurrence of Middle East Respiratory Syndrome coronavirus (MERS-CoV) outbreaks.
We obtained the data on the prevalence and occurrence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection from the World Health Organization (WHO) for all the MERS cases reported from the various countries and their allied ministries. We also recorded the research documents published in various global scientific journals on the seasonal occurrence of MERS-CoV infection during the period 2012-2017.
Worldwide 2048 laboratory confirmed cases of MERS-CoV infection were reported from June 2012 to the Dec 2017. 1680 (82.03%) cases were from the Saudi Arabia and 368 (17.96%) cases were reported from the other countries of the world. The maximum number of cases reported in June was 474 (23.14%). 287 (14.01%) cases were reported from Saudi Arabia and remaining 187 (9.13%) cases were reported from all over the world. The number of cases reported from April to June was 396 (19.33%) while the cases encountered from October to December were 231 (11.27%).
The highest global seasonal occurrence of Middle East Respiratory Syndrome coronavirus-MERS-CoV outbreak cases were found in the month of June, while the lowest was found in the month of January during the period of 2012 to 2017. The pattern of MERS-CoV infections has been observed to have seasonal variations. It is suggested that the health officials should highlight the seasonal occurrence of MERS-CoV outbreak and take better preventive measures to minimize the disease burden nationally and globally.
中东呼吸综合征冠状病毒（MERS-CoV）是一场不断演变的全球卫生危机。尽管最近做出了努力，但人们对 MERS-CoV 季节性多样性的认识仍存在许多显著差距。我们旨在调查中东呼吸综合征冠状病毒（MERS-CoV）暴发的全球季节性发生情况。
我们从世界卫生组织（WHO）获得了有关 MERS 病例的流行率和发生情况的数据，这些病例来自各国及其相关部委报告的所有 MERS 病例。我们还记录了 2012 年至 2017 年期间全球科学期刊上发表的关于 MERS-CoV 感染季节性发生的研究文献。
2012 年 6 月至 2017 年 12 月，全球报告了 2048 例实验室确诊的 MERS-CoV 感染病例。1680 例（82.03%）来自沙特阿拉伯，368 例（17.96%）来自世界其他国家。6 月报告的病例数最多，为 474 例（23.14%）。287 例（14.01%）来自沙特阿拉伯，其余 187 例（9.13%）来自世界各地。4 月至 6 月报告的病例数为 396 例（19.33%），而 10 月至 12 月报告的病例数为 231 例（11.27%）。
2012 年至 2017 年期间，全球 MERS-CoV 暴发的季节性发生病例最多的月份是 6 月，而最低的月份是 1 月。MERS-CoV 感染模式存在季节性变化。建议卫生官员重点关注 MERS-CoV 暴发的季节性发生，并采取更好的预防措施，以减轻国家和全球的疾病负担。
